Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial

Gout-associated uric acid crystals activate the NALP3 inflammasome

Fabio Martinon, Virginie Pétrilli, Annick Mayor et al. · Nature · 2006 · 5.2K citations

Life Sciences, Cell Biology, Immunology +11

Clinical Significance of Reported Changes in Pain Severity☆☆☆★

Knox H. Todd, Kathleen G Funk, Joseph P Funk et al. · Annals of Emergency Medicine · 1996 · 1.1K citations

Medicine, Physical Medicine, Pain Management +15

2012 American College of Rheumatology guidelines for management of gout. Part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis

Dinesh Khanna, Puja Khanna, John FitzGerald et al. · Arthritis Care & Research · 2012 · 731 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation

Carlo Marchetti, Benjamin J. Swartzwelter, Fabia Gamboni et al. · Proceedings of the National Academy of Sciences · 2018 · 559 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

High versus low dosing of oral colchicine for early acute gout flare: Twenty‐four–hour outcome of the first multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison colchicine study

Robert Terkeltaub, Daniel E. Furst, Katherine Bennett et al. · Arthritis & Rheumatism · 2010 · 530 citations

Medicine, Pharmacology, Pharmacotherapy +16